Shree Ram Proteins Ltd: AGM Voting Results Show Strong Shareholder Support
Shree Ram Proteins Limited's 17th AGM was held on March 5, 2026, via VC. All resolutions, including financial statement adoption, director appointments, capital increase, and borrowing powers, passed with overwhelming shareholder support. The company submitted voting results and the Scrutinizer's Report on March 6, 2026.
This is a routine disclosure of voting results from an AGM, which is a standard corporate event. While positive, it does not introduce new material information that would significantly impact the company's operations or stock price.
The announcement details the successful conclusion of the AGM with all resolutions receiving strong shareholder approval, indicating positive corporate governance and shareholder confidence.
Shree Ram Proteins Limited has announced the voting results of its 17th Annual General Meeting (AGM), which was held on Thursday, March 05, 2026, through Video Conferencing (VC) along with remote e-voting.
The meeting commenced at 2:00 PM IST. Shareholders participated either through remote e-voting or during the AGM via VC/OAVM.
A total of 41,943 shareholders were on record as of the cut-off date, February 26, 2026. Of these, 41 shareholders, comprising 4 from the Promoter and Promoter Group and 37 from the Public category, attended the meeting through Video Conferencing. The company submitted consolidated voting results and the Scrutinizer’s Report, prepared by CS Payal Dhamecha, to the National Stock Exchange of India Limited on March 06, 2026.
All resolutions presented at the AGM received overwhelming support from shareholders. Key resolutions included the adoption of the audited financial statements for the financial year ended March 31, 2025, the re-appointment of a director, an increase in authorized share capital, the regularization and appointment of Ms. Naaz Jaiswal and Mr. Jayvir Vajubhai Kuvadiya as Independent Directors, the appointment of M/s. Payal Dhamecha & Associates as Secretarial Auditor for five years, ratification of the Cost Auditor's remuneration, and authority to the Board to borrow money under Section 180(1)(c) of the Companies Act, 2013, along with other matters specified under Section 180(1)(a). All resolutions passed with a significant majority, with most receiving 100% of the votes polled in favor.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.